Novel halogenase PezW shows potential for halogenating phenazines, indicating new avenues for antimicrobial agents.
Halogenated phenazines hold promise as antimicrobial and antibiofilm agents, yet are mainly accessed via chemical synthesis. Herein, we report PezW, a novel single-component flavin-dependent halogenase (FDH) that halogenates phenazine scaffolds, notably enabling enzymatic synthesis of bioactive 2-bromo-1-hydroxyphenazine (2d) and 2,4-bromo-1-hydroxyphenazine (2f). Structural modeling and mutagenesis revealed key residues critical for substrate binding and catalysis. These findings highlight PezW's potential as a biocatalyst for the synthesis of halogenated phenazines with pharmaceutical relevance.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: